Financials
Financial year 2025
Surginamics from Gent, company number BE0886824973, closed financial year 2025 with a result of € 8,793 after tax. For that financial year Surginamics recorded a gross margin of € 13,260 and equity of € 91,534. Compared with financial year 2024, the result moved from € 6,197 to € 8,793. Profitable, and profit is growing. The buffer shrank hard: equity is 54 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.
€ 91,534
▼ 54% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 8,793
▲ 42% vs 2024
Profit after tax over the fiscal year.
€ 119,472
▲ 86% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 118,227 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 2,029
▼ 47% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 66,696
▲ € 64,993 vs 2024
€ 14,649 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 9,008
▲ 21% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 39,003
▲ 250% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 56,079 | € 39,421 | € 30,732 | € 13,260 | ▼ 57% |
| Profit after taxes | € 33,990 | € 13,180 | € 6,197 | € 8,793 | ▲ 42% |
| Equity | € 207,801 | € 194,771 | € 200,968 | € 91,534 | ▼ 54% |
| Total debts | € 143,405 | € 83,926 | € 38,391 | € 128,893 | ▲ 236% |
| Cash | € 59,803 | € 30,432 | € 64,385 | € 119,472 | ▲ 86% |
| Retained profit | € 207,051 | € 194,021 | € 200,218 | € 90,784 | ▼ 55% |
| Dividend | € 99,614 | € 26,210 | € 0 | € 118,227 | |
| Bank debt | € 21,891 | € 11,854 | € 1,703 | € 66,696 | ▲ € 64,993 |
| Balance sheet total | € 351,207 | € 278,697 | € 239,359 | € 220,427 | ▼ 8% |
Key figures of Surginamics, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Surginamics?
What happened at Surginamics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 8,793 (▲ 42% vs 2024). Source: NBB ↗
- New establishment in Deinze. KBO
- Start of the company according to the CBE. KBO
In short
From € 33,990 profit in 2022 to € 8,793 profit in 2025.
Paid € 31,833 in corporate taxes since 2022.
Best year ever: 2022, with € 33,990 profit.
Paid out € 244,051 in dividends to the owners in total.
Management
Behind Surginamics is MICHEL DE GEEST.
Directors
According to the 2025 annual accounts
MICHEL DE GEEST
Director
Establishments
Establishment units
Physical locations of this company
James Ensorlaan 27
9051 Gent
Kerrebroek 22A
9850 Deinze
Active since 30 January 2007
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0886.824.973
- VAT number
- BE 0886.824.973
- Registered office
- James Ensorlaan 27, 9051 Gent
- Names & denominations
- Surginamics
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 January 2007
- Peppol
- Active · Active since 10 Nov 2025
- Activities · NACE
Handelsbemiddeling in de groothandel in andere specifieke goederen
Organisatie van congressen en beurzen